Celecoxib and Curcumin Additively Inhibit the Growth of Colorectal Cancer in a Rat Model

Publisher： Karger

E-ISSN： 1421-9867|74|3-4|140-144

ISSN： 0012-2823

Source： Digestion, Vol.74, Iss.3-4, 2007-04, pp. : 140-144

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Curcumin reverses attenuated carbachol-induced contraction of the colon in a rat model of colitis

By Lubbad Asmaa   Oriowo Mabayoje   Khan Islam  

Scandinavian Journal of Gastroenterology, Vol. 44, Iss. 2, 2009-02 ,pp. : 187-194

Informa Healthcare

Access to resources Recommend Favorite

Growth Hormone Receptor Expression in Human Colorectal Cancer

By Yang Xiaodong   Liu Fukun   Xu Zhe   Chen Che   Li Gang   Wu Xiaoyu   Li Jieshou  

Digestive Diseases and Sciences, Vol. 49, Iss. 9, 2004-09 ,pp. : 1493-1498

Springer Publishing Company

Access to resources Recommend Favorite

Anthocyanins Prevent Colorectal Cancer Development in a Mouse Model

By  

Digestion, Vol. 95, Iss. 4, 2017-05 ,pp. : 275-280

Karger

Access to resources Recommend Favorite

Rofecoxib does not inhibit aberrant crypt foci formation but inhibits later steps in the development of experimental colorectal cancer: Rofecoxib in experimental colon cancer

By Perše Martina   Zebic Ana   Cerar Anton  

Scandinavian Journal of Gastroenterology, Vol. 40, Iss. 1, 2005-01 ,pp. : 61-67

Informa Healthcare

Access to resources Recommend Favorite

Fibroblast Growth Factor Receptor 1 as a Putative Therapy Target in Colorectal Cancer

By  

Digestion, Vol. 88, Iss. 3, 2013-10 ,pp. : 172-181

Karger

Access to resources Recommend Favorite